Literature DB >> 7927857

Handling covariates in population pharmacokinetics.

F Mentré1, A Mallet.   

Abstract

Population models were developed to analyze processes, described by parametric models, from measurements obtained in a sample of individuals. In order to analyze the sources of interindividual variability, covariates may be incorporated in the population analysis. The exploratory analyses and the two-stage approaches which use standard non-linear regression techniques are simple tools to select meaningful covariates. The global population approaches may be divided into two classes within which the covariates are handled differently: the parametric and the non-parametric methods. The power as well as the limitations of each approach regarding handling of covariates are illustrated and compared using the same data set which concerns the pharmacokinetics of gentamicin in neonates. With parametric approaches a second-stage model between structural parameters and covariates has to be defined. In the non-parametric method the joint distribution of parameters and covariates is estimated without parametric assumptions; however, it is assumed that covariates are observed with some error and parameters involved in functional relationships are not estimated. The important results concerning gentamicin in neonates were found by the two methods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927857     DOI: 10.1016/0020-7101(94)90092-2

Source DB:  PubMed          Journal:  Int J Biomed Comput        ISSN: 0020-7101


  10 in total

1.  Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate.

Authors:  Maria Cusato; Massimo Allegri; Tekla Niebel; Pablo Ingelmo; Monica Broglia; Antonio Braschi; Mario Regazzi
Journal:  Eur J Clin Pharmacol       Date:  2010-11-16       Impact factor: 2.953

2.  A new approach to modeling covariate effects and individualization in population pharmacokinetics-pharmacodynamics.

Authors:  Tze Leung Lai; Mei-Chiung Shih; Samuel P Wong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-10       Impact factor: 2.745

3.  Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method.

Authors:  F Mesnil; F Mentré; C Dubruc; J P Thénot; A Mallet
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

Review 4.  The role of population PK-PD modelling in paediatric clinical research.

Authors:  Roosmarijn F W De Cock; Chiara Piana; Elke H J Krekels; Meindert Danhof; Karel Allegaert; Catherijne A J Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2010-03-26       Impact factor: 2.953

5.  Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models.

Authors:  G L Rosner; P Müller
Journal:  J Pharmacokinet Biopharm       Date:  1997-04

6.  Semiparametric Bayesian classification with longitudinal markers.

Authors:  Rolando De la Cruz-Mesía; Fernando A Quintana; Peter Müller
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2007-03       Impact factor: 1.864

7.  Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity.

Authors:  F Mentré; S Escolano; B Diquet; J L Golmard; A Mallet
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Modeling interindividual variability in physiologically based pharmacokinetics and its link to mechanistic covariate modeling.

Authors:  W Huisinga; A Solms; L Fronton; S Pilari
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-09-26

9.  Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study.

Authors:  Jessica M Heijdra; Wala Al Arashi; Nico C B de Jager; Michael E Cloesmeijer; Laura H Bukkems; Christian M Zwaan; Frank W G Leebeek; Ron A A Mathôt; Marjon H Cnossen
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692

10.  Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria.

Authors:  Annemarie R Kreeftmeijer-Vegter; Mariana de Mendonça Melo; Peter J de Vries; Rob Koelewijn; Jaap J van Hellemond; Perry J J van Genderen
Journal:  Malar J       Date:  2013-03-27       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.